Market - Page 4 of 313 - Express Pharma

Neovantage Innovation Parks secures a green loan for its life sciences real estate portfolio

Migraine market to reach $16.4 billion in 7MM by 2033, forecasts GlobalData

Surge in pharma funding observed in August 2024, reached $135 mn

Emcure launches Arth, aims to alleviate symptoms of menopause

Indian Immunologicals unveils pediatric dose of indigenous Hepatitis A vaccine, Havisure

NATCO Canada announces $ 8 mn investment in eGenesis

Lupin launches Mirabegron Extended-Release Tablets in the US

WHO’s mpox response aims to reduce disease burden, provides scope for developers

Alkem signs non-exclusive patent license agreement with Takeda to commercialise Vonoprazan in India

Sun Pharma introduces STARIZO (Tedizolid Phosphate) in India for ABSSSI